Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PWR vs MRNA✓SelectedUSD · MRNAPWR vs MRNA performance historyLatest closeAs of-4.83%11/20
Stock and ETF performance explorer

PWR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+367.2%
MRNA return
-27.3%
Excess return
+394.4%
Maximum drawdown
-35.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.8%-2.2%-2.7%-4.7%
7D-7.1%-12.7%+5.6%-6.6%
30D-7.0%-20.7%+13.7%-6.2%
3M-15.6%+46.3%-61.9%-17.0%
6M-21.2%+305.2%-326.5%-30.1%
YTD+32.6%+561.2%-528.7%+9.7%
1Y+30.2%+772.1%-741.9%+3.9%
3Y+204.6%+147.0%+57.7%+170.2%
All+367.2%-27.3%+394.4%+339.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling